Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| Haemonetics Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| Haemonetics Corporation, Medical Equipment Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| Haemonetics Corporation, Medical Equipment, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| Haemonetics Corporation, Medical Equipment, Deals By Market, 2010 to YTD 2016 | 9 | 1 |
| Haemonetics Corporation, Medical Equipment, Deals Summary, 2010 to YTD 2016 | 10 | 1 |
| Haemonetics Corporation, Medical Equipment, Deal Details | 11 | 9 |
| Asset Purchase | 11 | 1 |
| Haemonetics Completes Acquisition Of Blood Collection, Filtration And Processing Product Lines From Pall For US$551 Million | 11 | 2 |
| Partnerships | 13 | 1 |
| HemaCare Enters Into Licensing Agreement With Haemonetics | 13 | 1 |
| Haemonetics Enters Into Licensing Agreement With Alba Bioscience | 14 | 1 |
| Cerus Enters into Agreement with Haemonetics | 15 | 1 |
| Acquisition | 16 | 1 |
| Haemonetics Completes Acquisition Of Hemerus Medical, Leukoreduction Technologies Provider, For Up To US$41 Million | 16 | 2 |
| Haemonetics Completes Tender Offer For Acquisition Of Global Med Technologies | 18 | 2 |
| Haemonetics Corporation - Key Competitors | 20 | 1 |
| Key Employees | 21 | 1 |
| Locations And Subsidiaries | 22 | 3 |
| Head Office | 22 | 1 |
| Other Locations &Subsidiaries | 22 | 3 |
| Recent Developments | 25 | 1 |
| Financial Announcements | 25 | 1 |
| May 02, 2016: Haemonetics Reports 4th Quarter Fiscal 2016 Revenue of $243 Million, Constant Currency Revenue Growth of 10% and 7% As Reported | 25 | 4 |
| Feb 01, 2016: Haemonetics Reports 3rd Quarter Fiscal 2016 Revenue of $233 Million, Constant Currency Revenue Growth of 4% and 1% As Reported | 29 | 3 |
| Nov 04, 2015: Haemonetics Reports 2nd Quarter Fiscal 2016 Revenue of $220 Million and Adjusted EPS of $0.44, Affirms Recent Full Fiscal Year Guidance | 32 | 4 |
| Jul 27, 2015: Haemonetics Reports 1St Quarter Fiscal 2016 Revenue Of $213 Million and Adjusted Eps Of $0.35, Reaffirms Full Fiscal Year Guidance | 36 | 4 |
| Apr 27, 2015: Haemonetics Reports 4th Quarter Fiscal 2015 Revenue of $226 Million and Adjusted EPS of $0.47; Full Year Revenue of $910 Million and Adjusted EPS of $1.85; | 40 | 4 |
| Jan 29, 2015: Haemonetics Reports 3rd Quarter Fiscal 2015 Revenue of $232 Million and Adjusted EPS of $0.53; Reaffirms Revenue and EPS Guidance | 44 | 4 |
| Corporate Communications | 48 | 1 |
| Aug 01, 2016: Haemonetics Appoints Bill Burke CFO | 48 | 1 |
| May 09, 2016: Haemonetics Announces Christopher Simon as President and Chief Executive Officer | 49 | 1 |
| Apr 14, 2016: Haemonetics Announces CFO's Retirement | 50 | 1 |
| Sep 29, 2015: Haemonetics Corporation Appoints Ron Gelbman as Interim CEO; CEO Brian Concannon Resigns | 51 | 1 |
| Apr 27, 2015: Haemonetics Expands Executive Management Roles To Complement Global Growth Strategy | 52 | 1 |
| Government and Public Interest | 53 | 1 |
| Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean | 53 | 2 |
| Other Significant Developments | 55 | 1 |
| May 09, 2016: Haemonetics Provides Fiscal 2017 Guidance | 55 | 1 |
| Appendix | 56 | 1 |
| Methodology | 56 | 1 |
| About GlobalData | 56 | 1 |
| Contact Us | 56 | 1 |
| Disclaimer | 56 | 1 |